Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tears Naturale II - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Tears Naturale II

Approved

STANDARD

Tears Naturale II

Alcon Singapore Manufacturing Pte. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0cdce73ab92308ca
Company: Alcon Singapore Manufacturing Pte. Ltd.
Type: Standard

Approval Details

Approval Id: 0cdce73ab92308ca
Drug Approval Philippines Name: Tears Naturale II
Product Name: Tears Naturale II
Registration Number: DR-XY45764
Brand Name: Tears Naturale II
Generic Name: Dextran 70 + Hypromellose
Dosage Form: Ophthalmic Solution
Dosage Strength: 1mg/ 3mg per mL
Manufacturer: Alcon Singapore Manufacturing Pte. Ltd.
Importer: Alcon Laboratories (Phils.) Inc.
Company Detail Path: /organization/alcon-singapore-manufacturing-pte-ltd
Issuance Date: 28 December 2021
Expiry Date: 27 January 2027
Pharmacologic Category: Eye Lubricant
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0cdce73ab92308ca

Type

Standard

Back to Philippines FDA Approvals